Dr. Patrick E Sewell MD

Founder & Chief Executive Officer

“The genome is not a mystery to be solved — it is an instruction set to be read.”

Our work is translation: from genetic sequence to clinical outcome, with the precision that institutional medicine demands. Dr. Sewell brings an exceptional track record in regenerative medicine with extensive IP-protected research programs development, founding Triple Helix Science with a sovereign-partnership focus under his direct leadership.

Clinical Departments & Programs Directed

Code A

Interventional Oncology – Neuro – Vascular

Targeted image-guided therapies and precision oncologic gene modulation.

View Specialty ↗

Disciplined Clinical Governance Framework

All clinical translation protocols, vector applications, and physician referral pathways at Triple Helix Science are overseen by our medical executive leadership under international GCP, GLP, and sovereign regulatory standards.